Delivery Order SPE2DR25D7909-SPE2DR26FX7HK
Award Date 2/6/26
Potential Completion Date 2/9/26
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $1,566.00 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for procainamide 1 gram/10 mL vial (10 mL) with an ultimate completion date of February 6, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside used.</p>
- <p>The Defense Logistics Agency issued a $1,664.58 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Procainamide 1 gram/10 mL vials under a firm fixed-price arrangement. Place of performance is Conshohocken, PA. The order is due for ultimate completion on February 6, 2026.</p>
- <p>The Defense Logistics Agency issued a $6,231.94 delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for procainamide 1 gram/10 mL vial (10 mL) with an ultimate completion date of February 9, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price and was issued without a set-aside.</p>
- The Defense Logistics Agency awarded a $1,566.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Procainamide 1 gram/10 mL vials on February 4, 2026, with an ultimate completion date of February 5, 2026. This competitive award, which carried no set-aside designation, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used in military and federal healthcare systems to manage cardiac...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Procainamide 1,000 mg/2 mL vials at a ceiling value of $1,077.86. The contract utilizes firm fixed price pricing with a delivery completion deadline of December 19, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without any set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Procainamide 1 gram/10 mL vials with a contract value of $1,652.29. This non-set-aside, competitively awarded delivery order is a firm fixed price contract with performance completion scheduled for December 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $3,164.53. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Procainamide 1 gram/10 milliliter vials. This competitive award, with a ceiling value of $9,028.89, represents a firm fixed-price delivery order to be completed by September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency awarded a $5,449.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Procainamide 1 gram/10 milliliter vials (10 milliliters total). The contract is set to be completed by January 2, 2026, with performance to take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply...
- SPE2DR25D7909Indefinite Delivery Contract
- SPE2DR25D7909-SPE2DR26FX7HKDelivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Procainamide 1 gram/10 mL vials with a ceiling value of $6,795.48. Place of performance is Conshohocken, PA. Ultimate completion date is February 9, 2026. The order is priced firm fixed price and carries no set-aside designation.
Generated 5/7/26, 10:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 2/5/26 |